GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genedrive PLC (LSE:GDR) » Definitions » Institutional Ownership

Genedrive (LSE:GDR) Institutional Ownership : 0.30% (As of Jun. 27, 2025)


View and export this data going back to 2007. Start your Free Trial

What is Genedrive Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Genedrive's institutional ownership is 0.30%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Genedrive's Insider Ownership is 2.19%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Genedrive's Float Percentage Of Total Shares Outstanding is 0.00%.


Genedrive Institutional Ownership Historical Data

The historical data trend for Genedrive's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genedrive Institutional Ownership Chart

Genedrive Historical Data

The historical data trend for Genedrive can be seen below:

2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31 2025-04-30 2025-05-31
Institutional Ownership 0.30 0.30 0.30 0.30 0.30 0.30 0.30 0.30 0.30 0.30

Genedrive Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Genedrive Business Description

Traded in Other Exchanges
Address
Grafton Street, The Incubator Building, Manchester, GBR, M13 9XX
Genedrive PLC is a holding company engaged in the molecular diagnostics business. It operates in one operating segment named Diagnostics which is engaged in the Genedrive Point of need molecular diagnostics platform for the diagnosis of infectious diseases and use in patient stratification (genotyping), pathogen detection, and other indications. Geographically the majority of the revenue is derived from the United Kingdom and also has its presence in Europe, United States of America and Rest of the World.

Genedrive Headlines

No Headlines